Most Recent
Four doctors named in a class action over cosmetic surgeries performed at Daniel Lanzer’s clinic in Sydney can't dodge claims they are liable as accessories for alleged misleading social media ads.
Biotech Regeneron and drug company Bayer have wasted no time in challenging a decision that cleared the way for generic pharmaceutical manufacturer Sandoz to launch a version of top selling Eylea.
Junior doctors in Tasmania are the latest to bring a class action seeking compensation for years of alleged unpaid overtime work at the state’s major hospitals.
Orthopaedic surgeon Dr Munjed Al Muderis has appealed his loss in a defamation case against Fairfax and its owner Nine, after a judge found media reports of unethical and profit-driven promotion of an experimental procedure were substantially true.
After more than a year on ice, two class actions against age care facilities over COVID-19 outbreaks are set to resume late this year, following a month-long criminal trial that kicks off next week.
A junior Ashurst lawyer's failure to register a drug wholesaler's $51 million security interest over a group of Infinity pharmacies was inadvertent, a judge has found in granting a bid to extend the deadline for registration.
Fertility services provider Genea is facing a class action investigation over a data breach that led to sensitive patient information being published on the dark web.
A court has ruled that media reports accusing well-known orthopaedic surgeon Dr Munjed Al Muderis of unethical and profit-driven promotion of an experimental procedure were substantially true, tossing his defamation suit against Fairfax and its owner Nine.
The High Court has rejected Novartis' plea that it overturn a ruling that found an extension of the term of the patent for its heart drug Entresto was invalidly granted.
Mayne Pharma and US drug maker Cosette have agreed to postpone the start of trial in a case over the termination of a $672 million merger to allow for late amendments.